Perfuse Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
611 Gateway Blvd Ste 910, South San Fran...Website
www.perfusetherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Perfuse Therapeutics
Perfuse Therapeutics is focused on developing innovative therapies aimed at reducing blindness, particularly through improving blood flow to the retina. Their primary product is a first-in-class endothelin antagonist designed to enhance ocular blood flow, targeting conditions such as glaucoma and diabetic retinopathy. The company is backed by a team with extensive expertise in ocular drug discovery and a strong network of venture capital firms specializing in ophthalmology. Their mission addresses the significant global health issue of blindness caused by these prevalent ocular diseases.Explore more
Perfuse Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Perfuse Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Perfuse Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Perfuse Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Perfuse Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Perfuse Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Perfuse Therapeutics
Earning: See what the market has to say on Perfuse Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Perfuse Therapeutics has new funding data
Perfuse Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Perfuse Therapeutics
Compare insights from companies similar to Perfuse Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Perfuse Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Perfuse Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Perfuse Therapeutics.
Perfuse Therapeutics Tech Stack
A closer look at the technologies used by Perfuse Therapeutics
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Person-Based
Person-Based
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Perfuse Therapeutics
Sign Up For FreeTo access detailed company insights
Perfuse Therapeutics is focused on developing innovative therapies aimed at reducing blindness, particularly through improving blood flow to the retina. Their primary product is a first-in-class endothelin antagonist designed to enhance ocular blood flow, targeting conditions such as glaucoma and diabetic retinopathy. The company is backed by a tea... Read More
